Chlamydia pneumoniae and coronary heart disease: Coincidence, association, or causation?

BMJ

Volumn 314, Issue 7097, 1997, Pages 1778-

  Gupta, Sandeep ^a   Camm, A John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ATHEROSCLEROTIC PLAQUE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CIGARETTE SMOKING; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; EDITORIAL; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SEROEPIDEMIOLOGY;

CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY DISEASE; HUMANS;

EID: 0030985317     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.314.7097.1778     Document Type: Editorial

References (15)

1. Cook PJ, Lip GYH. Infectious agents and atherosclerotic vascular disease. Q J Med 1996; 89: 727–735.
2. Grayston IT, Campbell LA, Kuo C-C, Mordhurst CH, Saikku P, Thom DH, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161: 618–625.
3. Saikku P, Mattila KJ, Nieminen MS, Huttunen JK, Leinonen M, Ekman MR, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2:983–6.
4. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman M-R, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992; 116: 273–277.
5. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68–72.
6. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levy J, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995; 30: 121–128.
7. Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841–849.
8. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MT, Karagounis LA, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27: 1555–1561.
9. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102–106.
10. Holland MI, Bailey RL, Ward ME, Morrison EI, Whittle HC, Mabey DC. Cell mediated immune responses to Chlamydia trachomatis in scarring trachoma. Proc Eur Soc Chlamydia Res 1992; 2: 134.
11. Patel P, Carrington D, Strachan DP, Leatham EW, Goggin P, Northfield TC, et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994; 343: 1634–1635.
12. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061–1065.
13. Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995; 73: 10–13.
14. Gupta S, Leatham EW, Carrington D, Mendall MA, Ireson N, Tooze J, et al. The effect of azithromycin in post myocardial infarction patients with elevated Chlamydia pneumoniae antibody titres [abstract]. J Am Coll Cardiol 1997; 755: 209.
15. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation (in press).